Rhonda Rowan
Psychiatric/Mental Health · Vancouver, WANPI 1427568492
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 513 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 513 payments — averaging $19.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Supernus Pharmaceuticals, Inc.$1K
- Alkermes, Inc.$976
- Teva Pharmaceuticals USA, Inc.$814
- Corium, LLC$622
- Johnson & Johnson$598
- plus $4K from 16 others
What the payments were for
- Food & beverage$9,985100%
- Education$20%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 100 | $1,676 |
| Supernus Pharmaceuticals, Inc. | 75 | $1,178 |
| Alkermes, Inc. | 39 | $976 |
| Teva Pharmaceuticals USA, Inc. | 33 | $814 |
| Corium, LLC | 30 | $622 |
| Johnson & Johnson | 20 | $598 |
| Vanda Pharmaceuticals Inc. | 30 | $575 |
| Bausch Health US, LLC | 37 | $558 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $525 |
| Otsuka America Pharmaceutical, Inc. | 17 | $513 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $421 |
| Axsome Therapeutics, Inc. | 11 | $370 |
| Lundbeck LLC | 22 | $350 |
| Neurocrine Biosciences, Inc. | 10 | $280 |
| Sunovion Pharmaceuticals Inc. | 13 | $217 |
| Ironshore Pharmaceuticals Inc. | 5 | $79 |
| Noven Therapeutics, LLC | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Adlon Therapeutics L.p. | 2 | $34 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,988 in reported general payments places this provider in the 95th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lisdexamfetamine Dimesylate | 14 | $4,405 |
| Lurasidone Hcl | 13 | $2,297 |
| Quetiapine Fumarate | 22 | $246 |
| Prazosin Hcl | 17 | $231 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 11 | $198 |
| Lamotrigine | 16 | $34 |
| Alprazolam | 11 | $0 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Vancouver
- Brendan RoeVancouver$18K
- John JohnsonVancouver$8K
- Nwamaka EmeruemVancouver$8K
- Hsiangfeng TsaiVancouver$5K
- David CaliffVancouver$4K
- Cailin JarrellVancouver$4K
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.